KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Inventory (2016 - 2026)

Bristol Myers Squibb has reported Inventory over the past 18 years, most recently at $2.8 billion for Q1 2026.

  • Quarterly Inventory rose 3.38% to $2.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Mar 2026, up 3.38% year-over-year, with the annual reading at $2.7 billion for FY2025, 5.2% up from the prior year.
  • Inventory was $2.8 billion for Q1 2026 at Bristol Myers Squibb, up from $2.7 billion in the prior quarter.
  • Over five years, Inventory peaked at $3.3 billion in Q3 2024 and troughed at $2.1 billion in Q3 2022.
  • The 5-year median for Inventory is $2.7 billion (2023), against an average of $2.6 billion.
  • Year-over-year, Inventory soared 36.78% in 2024 and then dropped 17.23% in 2025.
  • A 5-year view of Inventory shows it stood at $2.3 billion in 2022, then rose by 13.81% to $2.7 billion in 2023, then decreased by 3.94% to $2.6 billion in 2024, then increased by 5.2% to $2.7 billion in 2025, then grew by 2.45% to $2.8 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Inventory are $2.8 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.8 billion (Q3 2025).